Department of Endocrinology, Diabetes, Nutrition, and Hypertension, University Hospital of Geneva, 4 Rue Gabrielle-Perret-Gentil, CH-1211 Geneva 14, Switzerland.
J Clin Endocrinol Metab. 2013 Nov;98(11):4446-56. doi: 10.1210/jc.2013-2568. Epub 2013 Aug 26.
The circadian clock represents the body's molecular time-keeping system. Recent findings revealed strong changes of clock gene expression in various types of human cancers.
Due to emerging evidence on the connection between the circadian oscillator, cell cycle, and oncogenic transformation, we aimed to characterize the circadian clockwork in human benign and malignant thyroid nodules.
Clock transcript levels were assessed by quantitative RT-PCR in thyroid tissues. To provide molecular characteristics of human thyroid clockwork, primary thyrocytes established from normal or nodular thyroid tissue biopsies were subjected to in vitro synchronization with subsequent clock gene expression analysis by circadian bioluminescence reporter assay and by quantitative RT-PCR.
The expression levels of the Bmal1 were up-regulated in tissue samples of follicular thyroid carcinoma (FTC), and in papillary thyroid carcinoma (PTC), as compared with normal thyroid and benign nodules, whereas Cry2 was down-regulated in FTC and PTC. Human thyrocytes derived from normal thyroid tissue exhibited high-amplitude circadian oscillations of Bmal1-luciferase reporter expression and endogenous clock transcripts. Thyrocytes established from FTC and PTC exhibited clock transcript oscillations similar to those of normal thyroid tissue and benign nodules (except for Per2 altered in PTC), whereas cells derived from poorly differentiated thyroid carcinoma exhibited altered circadian oscillations.
This is the first study demonstrating a molecular makeup of the human thyroid circadian clock. Characterization of the thyroid clock machinery alterations upon thyroid nodule malignant transformation contributes to understanding the connections between circadian clocks and oncogenic transformation. Moreover, it might help in improving the thyroid nodule preoperative diagnostics.
生物钟代表着人体的分子计时系统。最近的研究发现,时钟基因表达在各种人类癌症中发生了强烈变化。
由于昼夜振荡器、细胞周期和致癌转化之间的联系有新的证据,我们旨在描述人类良性和恶性甲状腺结节中的生物钟机制。
通过定量 RT-PCR 评估甲状腺组织中的时钟转录水平。为了提供人类甲状腺生物钟的分子特征,我们从正常或结节性甲状腺组织活检中建立的原代甲状腺细胞进行体外同步化,随后通过昼夜生物发光报告测定和定量 RT-PCR 分析时钟基因表达。
与正常甲状腺和良性结节相比,滤泡状甲状腺癌(FTC)和甲状腺乳头状癌(PTC)的组织样本中 Bmal1 的表达水平上调,而 Cry2 在 FTC 和 PTC 中下调。源自正常甲状腺组织的人甲状腺细胞表现出 Bmal1-luciferase 报告表达和内源性时钟转录物的高振幅昼夜振荡。源自 FTC 和 PTC 的甲状腺细胞表现出与正常甲状腺组织和良性结节相似的时钟转录物振荡(除了 PTC 中的 Per2 改变),而源自分化不良型甲状腺癌的细胞则表现出改变的昼夜振荡。
这是首次研究表明人类甲状腺生物钟的分子构成。描述甲状腺结节恶性转化时生物钟机制的改变有助于理解昼夜钟和致癌转化之间的联系。此外,它可能有助于改善甲状腺结节的术前诊断。